| Research Title | Researcher Name | Department | Publication | Date | |
|---|---|---|---|---|---|
| Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 03/12/2024 | View |
| ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 16/12/2024 | View |
| Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 17/12/2024 | View |
| ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 25/12/2024 | View |
| Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 26/12/2024 | View |
| ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment | Dr. Jitendra Nangal | Chemotherapy | Publication Name | 31/12/2024 | View |
Nangal Cancer Hospital & Research Institute, Bikaner is the destination for many cancer patients, not only from India, but also from Abroad. Patients from several countries have been visiting the Institute for Advanced Cancer Care.
Our Best Doctors
Compassionate care for all ages.
Medical College Rd, Near Traffic Police Thana, Adarsh Colony, Bikaner, Rajasthan 334001, India